vs
Side-by-side financial comparison of OLIN Corp (OLN) and RENAISSANCERE HOLDINGS LTD (RNR). Click either name above to swap in a different company.
RENAISSANCERE HOLDINGS LTD is the larger business by last-quarter revenue ($2.2B vs $1.7B, roughly 1.3× OLIN Corp). RENAISSANCERE HOLDINGS LTD runs the higher net margin — 23.5% vs -8.6%, a 32.1% gap on every dollar of revenue. On growth, OLIN Corp posted the faster year-over-year revenue change (-0.4% vs -36.8%). Over the past eight quarters, OLIN Corp's revenue compounded faster (0.9% CAGR vs -11.9%).
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.
RenaissanceRe Holdings Ltd is a Bermudian provider of reinsurance, insurance and other related business services. The company operates in reinsurance, insurance and ventures.
OLN vs RNR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $2.2B |
| Net Profit | $-143.2M | $515.8M |
| Gross Margin | 1.9% | — |
| Operating Margin | -9.4% | — |
| Net Margin | -8.6% | 23.5% |
| Revenue YoY | -0.4% | -36.8% |
| Net Profit YoY | -1517.8% | 72.6% |
| EPS (diluted) | $-1.25 | $6.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.7B | $3.0B | ||
| Q3 25 | $1.7B | $3.2B | ||
| Q2 25 | $1.8B | $3.2B | ||
| Q1 25 | $1.6B | $3.5B | ||
| Q4 24 | $1.7B | $2.3B | ||
| Q3 24 | $1.6B | $4.0B | ||
| Q2 24 | $1.6B | $2.8B |
| Q1 26 | — | $515.8M | ||
| Q4 25 | $-143.2M | $760.5M | ||
| Q3 25 | $43.7M | $916.5M | ||
| Q2 25 | $-2.8M | $835.4M | ||
| Q1 25 | $1.2M | $170.0M | ||
| Q4 24 | $10.1M | $-189.7M | ||
| Q3 24 | $-25.2M | $1.2B | ||
| Q2 24 | $72.3M | $503.9M |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 8.5% | — | ||
| Q2 24 | 14.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.4% | 42.5% | ||
| Q3 25 | 4.8% | 46.3% | ||
| Q2 25 | 2.0% | 41.8% | ||
| Q1 25 | 2.7% | -2.0% | ||
| Q4 24 | 2.8% | -3.6% | ||
| Q3 24 | 1.0% | 43.7% | ||
| Q2 24 | 8.3% | 25.0% |
| Q1 26 | — | 23.5% | ||
| Q4 25 | -8.6% | 25.6% | ||
| Q3 25 | 2.6% | 28.7% | ||
| Q2 25 | -0.2% | 26.1% | ||
| Q1 25 | 0.1% | 4.9% | ||
| Q4 24 | 0.6% | -8.3% | ||
| Q3 24 | -1.6% | 29.8% | ||
| Q2 24 | 4.4% | 17.8% |
| Q1 26 | — | $6.57 | ||
| Q4 25 | $-1.25 | $16.16 | ||
| Q3 25 | $0.37 | $19.40 | ||
| Q2 25 | $-0.01 | $17.20 | ||
| Q1 25 | $0.01 | $3.27 | ||
| Q4 24 | $0.10 | $-3.76 | ||
| Q3 24 | $-0.21 | $22.62 | ||
| Q2 24 | $0.62 | $9.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $1.6B |
| Total DebtLower is stronger | $2.8B | — |
| Stockholders' EquityBook value | $1.8B | $4.3B |
| Total Assets | $7.3B | $53.7B |
| Debt / EquityLower = less leverage | 1.55× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.6B | ||
| Q4 25 | $167.6M | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $175.6M | $1.7B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $2.8B | $2.3B | ||
| Q3 25 | $3.0B | $2.2B | ||
| Q2 25 | $3.0B | $2.3B | ||
| Q1 25 | $3.0B | $2.8B | ||
| Q4 24 | $2.7B | $1.9B | ||
| Q3 24 | $2.8B | $1.9B | ||
| Q2 24 | $2.8B | $2.0B |
| Q1 26 | — | $4.3B | ||
| Q4 25 | $1.8B | $11.6B | ||
| Q3 25 | $2.0B | $11.5B | ||
| Q2 25 | $2.0B | $10.8B | ||
| Q1 25 | $2.0B | $10.3B | ||
| Q4 24 | $2.0B | $10.6B | ||
| Q3 24 | $2.1B | $11.2B | ||
| Q2 24 | $2.1B | $10.2B |
| Q1 26 | — | $53.7B | ||
| Q4 25 | $7.3B | $53.8B | ||
| Q3 25 | $7.6B | $54.5B | ||
| Q2 25 | $7.7B | $54.7B | ||
| Q1 25 | $7.7B | $53.6B | ||
| Q4 24 | $7.6B | $50.7B | ||
| Q3 24 | $7.5B | $52.8B | ||
| Q2 24 | $7.7B | $51.6B |
| Q1 26 | — | — | ||
| Q4 25 | 1.55× | 0.20× | ||
| Q3 25 | 1.52× | 0.19× | ||
| Q2 25 | 1.52× | 0.21× | ||
| Q1 25 | 1.50× | 0.27× | ||
| Q4 24 | 1.34× | 0.18× | ||
| Q3 24 | 1.34× | 0.17× | ||
| Q2 24 | 1.31× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $321.2M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $321.2M | $483.0M | ||
| Q3 25 | $26.7M | $1.6B | ||
| Q2 25 | $212.3M | $1.5B | ||
| Q1 25 | $-86.0M | $157.8M | ||
| Q4 24 | $141.7M | $778.9M | ||
| Q3 24 | $189.9M | $1.5B | ||
| Q2 24 | $90.6M | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-44.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-147.4M | — | ||
| Q4 24 | $90.7M | — | ||
| Q3 24 | $146.6M | — | ||
| Q2 24 | $34.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -2.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -9.0% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 3.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.64× | ||
| Q3 25 | 0.61× | 1.73× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | -71.67× | 0.93× | ||
| Q4 24 | 14.03× | — | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | 1.25× | 2.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |
RNR
Segment breakdown not available.
